会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method and system for stimulating a heart of a patient
    • 刺激患者心脏的方法和系统
    • US08812109B2
    • 2014-08-19
    • US13593334
    • 2012-08-23
    • Andreas BlomqvistKjell Noren
    • Andreas BlomqvistKjell Noren
    • A61N1/00
    • A61N1/00A61N1/3627A61N1/36514A61N1/36564A61N1/3682A61N1/3684
    • In an implantable medical device and a method for stimulating a heart of a patient, at least one left atrial pressure (LAP) signal over a cardiac cycle is obtained. The A-wave is identified using the LAP signal and a maximum positive rate of change of the A-wave of the LAP signal is determined. The maximum positive rate of change of the A-wave corresponds to the rate which the pressure in the atrium raises as the atria contraction forces more blood into the ventricle during the very last stage of diastole. Further, AV and/or VV delay is adjusted in response to the maximum positive rate of change of the A-wave, wherein a reduction of the maximum positive rate of change of the A-wave indicates an AV and/or VV delay providing an enhanced hemodynamic performance.
    • 在可植入医疗装置和刺激患者心脏的方法中,获得心动周期上的至少一个左心房压力(LAP)信号。 使用LAP信号识别A波,并确定LAP信号的A波的最大正比率。 A波的最大阳性变化率对应于心房收缩期间压力升高的速率,因为心房收缩在舒张期的最后阶段迫使更多的血液进入心室。 此外,AV和/或VV延迟响应于A波的最大正的变化速率而被调整,其中A波的最大正的变化率的减小表示AV和/或VV延迟提供 增强血液动力学性能。
    • 4. 发明申请
    • METHOD AND SYSTEM FOR STIMULATING A HEART OF A PATIENT
    • 用于刺激患者心脏的方法和系统
    • US20130158620A1
    • 2013-06-20
    • US13593334
    • 2012-08-23
    • Andreas BlomqvistKjell Noren
    • Andreas BlomqvistKjell Noren
    • A61N1/365
    • A61N1/00A61N1/3627A61N1/36514A61N1/36564A61N1/3682A61N1/3684
    • In an implantable medical device and a method for stimulating a heart of a patient, at least one left atrial pressure (LAP) signal over a cardiac cycle is obtained. The A-wave is identified using the LAP signal and a maximum positive rate of change of the A-wave of the LAP signal is determined. The maximum positive rate of change of the A-wave corresponds to the rate which the pressure in the atrium raises as the atria contraction forces more blood into the ventricle during the very last stage of diastole. Further, AV and/or VV delay is adjusted in response to the maximum positive rate of change of the A-wave, wherein a reduction of the maximum positive rate of change of the A-wave indicates an AV and/or VV delay providing an enhanced hemodynamic performance.
    • 在可植入医疗装置和刺激患者心脏的方法中,获得心动周期上的至少一个左心房压力(LAP)信号。 使用LAP信号识别A波,并确定LAP信号的A波的最大正比率。 A波的最大阳性变化率对应于心房收缩期间压力升高的速率,因为心房收缩在舒张期的最后阶段迫使更多的血液进入心室。 此外,AV和/或VV延迟响应于A波的最大正的变化速率而被调整,其中A波的最大正的变化率的减小表示AV和/或VV延迟提供 增强血液动力学性能。
    • 6. 发明授权
    • Cardiomechanical assessment for cardiac resynchronization therapy
    • 心脏再同步治疗的心脏力学评估
    • US08211032B2
    • 2012-07-03
    • US13191253
    • 2011-07-26
    • Stuart O. SchecterKjell Noren
    • Stuart O. SchecterKjell Noren
    • A61B5/0452
    • A61N1/36514A61N1/36578
    • A first lead provides therapeutic stimulation to the heart and includes a first mechanical sensor that measures physical contraction and relaxation of the heart. A controller induces delivery of therapeutic stimulation via the first lead. The controller receives signals from the first mechanical sensor indicative of the contraction and relaxation; develops a template signal that corresponds to the contraction and relaxation; and uses the template signal to modify the delivery of therapeutic stimulations. In another arrangement, a second lead, with a second mechanical sensor also provides signals to the controller indicative of contraction and relaxation. The first mechanical sensor is adapted to be positioned at the interventricular septal region of the heart, and the second mechanical sensor is adapted to be positioned in the lateral region of the left ventricle. The controller processes the signals from the first mechanical sensor and the second mechanical sensor to develop a dysynchrony index.
    • 第一个引线提供对心脏的治疗刺激,并且包括测量心脏的身体收缩和松弛的第一机械传感器。 控制器通过第一引线诱导治疗性刺激。 控制器从第一机械传感器接收指示收缩和松弛的信号; 开发对应于收缩和放松的模板信号; 并使用模板信号修改治疗刺激的递送。 在另一种布置中,具有第二机械传感器的第二引线还向控制器提供指示收缩和松弛的信号。 第一机械传感器适于定位在心脏的室间隔区域,并且第二机械传感器适于定位在左心室的侧向区域中。 控制器处理来自第一机械传感器和第二机械传感器的信号以产生异步指数。
    • 9. 发明申请
    • METHOD AND APPARATUS FOR DETERMINING VARIATION OVER TIME OF A MEDICAL PARAMETER OF A HUMAN BEING
    • 用于确定人类医疗参数时间变化的方法和装置
    • US20100249864A1
    • 2010-09-30
    • US12438397
    • 2006-08-28
    • Karin JärverudKjell Noren
    • Karin JärverudKjell Noren
    • A61N1/362A61B5/103
    • A61B5/0205A61B5/0031A61B5/02028A61B5/0215A61B5/1116A61B5/686A61B5/7239A61N1/36564A61N1/3702
    • An apparatus for determining variation over time of a medical parameter of a human being obtained from a sensed signal has a sensor implantable in the human being for sensing the signal. A comparator compares at least one characteristic property, derived from the sensed signal obtained for at least one predetermined first level of activity of the human being, with corresponding reference property of a sensed reference signal, obtained for a predetermined reference level of activity of the human being, for determining a relation between the characteristic property of the sensed signal and the reference property. A trend determining unit determines trends in the medical parameter by analyzing the relation between the characteristic property of the sensed signal obtained at different times and the reference property. A corresponding method also function an implant for heart failure diagnostics also function as described. A sensor is then arranged to pick up dynamic mechanical information from the heart of the human being and generate a corresponding signal. A heart stimulator includes such an implant and a control unit arranged to control stimulation of the heart depending on determined trends in the medical parameter.
    • 用于确定从感测信号获得的人的医学参数随时间变化的装置具有可植入人体的用于感测信号的传感器。 比较器比较从针对人的至少一个预定的第一活动水平获得的感测信号导出的至少一个特征属性与针对人的预定参考活动水平获得的感测参考信号的相应参考特性 用于确定感测信号的特性与参考属性之间的关系。 趋势确定单元通过分析在不同时间获得的感测信号的特性与参考属性之间的关系来确定医疗参数的趋势。 相应的方法也可以用于心力衰竭诊断的植入物也起到所述的作用。 然后设置传感器以从人的心脏拾取动态机械信息并产生相应的信号。 心脏刺激器包括这样的植入物和控制单元,其被布置成根据医学参数中确定的趋势来控制心脏的刺激。
    • 10. 发明申请
    • Implantable Medical Device with Therapy Control
    • 具有治疗控制的植入式医疗器械
    • US20080294213A1
    • 2008-11-27
    • US12094534
    • 2005-11-30
    • Nils HolmstromKjell Noren
    • Nils HolmstromKjell Noren
    • A61N1/365
    • A61N1/36514A61B7/04A61N1/3627A61N1/36578A61N1/3684
    • A method for operating an implantable medical device to obtain substantially synchronized closure of the mitral and tricuspid valves based on sensed heart sounds includes sensing an acoustic energy; producing signals indicative of heart sounds of the heart of the patient over predetermined periods of a cardiac cycle during successive cardiac cycles; calculating a pulse width of such a signal; and iteratively controlling a delivery of the ventricular pacing pulses based on calculated pulse widths of successive heart sound signals to identify an RV interval or VV interval that causes a substantially synchronized closure of the mitral and tricuspid valve. A medical device for optimizing an RV interval or VV interval based on sensed heart sounds implements such a method and a computer readable medium encoded with instructions causes a computer to perform such a method.
    • 用于操作可植入医疗装置以基于感测到的心脏声音获得二尖瓣和三尖瓣的基本上同步闭合的方法包括感测声能; 在连续心脏周期期间产生指示心脏周期的预定周期的患者心脏的心脏声音的信号; 计算这种信号的脉冲宽度; 并且基于计算的连续心脏声音信号的脉冲宽度迭代地控制心室起搏脉冲的递送,以识别导致二尖瓣和三尖瓣的基本上同步闭合的RV间隔或VV间隔。 基于感测到的心脏声音优化RV间隔或VV间隔的医疗装置实现了这样的方法,并且用指令编码的计算机可读介质使得计算机执行这种方法。